Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.058 | 0.7 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |